InvestorsObserver
Sign Up Login

NUGS Cannabis Strategic Ventures

$0.01 $0.00 (-5.43%)
Add to Watchlist Compare
Overall

NUGS Stock Analysis Overview

What this means: InvestorsObserver gives Cannabis Strategic Ventures (NUGS) an overall rank of 29, which is below average. Cannabis Strategic Ventures is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 29 means that 71% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

NUGS Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

NUGS Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

NUGS Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

NUGS Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

NUGS Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

NUGS Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

NUGS Stock Analysis Overview

What this means: InvestorsObserver gives Cannabis Strategic Ventures (NUGS) an overall rank of 29, which is below average. Cannabis Strategic Ventures is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 29 means that 71% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full NUGS report

NUGS Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

NUGS Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

NUGS Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

NUGS Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

NUGS Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

NUGS Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Cannabis Strategic Ventures (NUGS) Analyst Forecast

NUGS Price, Volume, Earnings, and Dividend Date

  • Last Price $0.01
  • Previous Close $0.01
  • Change $0.00
  • Open $0.01
  • Volume 188,321
  • Avg. Volume (100-day) 1,308,141
  • Market Cap 1,909,071
  • Days Range 0.0071 - 0.008
  • 52-week Range 0 - 0.05
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date —
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Avg. Analyst Rec. Premium
  • Beta —
  • PEG Ratio —

Cannabis Strategic Ventures (NUGS) Company Description

Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.

Cannabis Strategic Ventures (NUGS) Stock Chart

View Interactive NUGS chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Drug Manufacturers - Specialty & Generic

Company Price
Optinose Inc (OPTN) (OPTN) $3.66
Avadel Pharmaceuticals Plc ADR (AVDL) (AVDL) $5.01
Assertio Therapeutics Inc (ASRT) (ASRT) $2.27
Evolus Inc (EOLS) (EOLS) $8.05
Alimera Sciences Inc (ALIM) (ALIM) $5.08
Societal Cdmo Inc (SCTL) (SCTL) $1.63
Sndl Inc (SNDL) (SNDL) $2.18
Kamada Ltd (KMDA) (KMDA) $4.51
Lantheus Holdings (LNTH) (LNTH) $70.33
Rockwell Medical IN (RMTI) (RMTI) $1.32